α-Synuclein (71-82) (human)
Need Assistance?
  • US & Canada:
    +
  • UK: +

α-Synuclein (71-82) (human)

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

A characteristic feature of individuals with neurodegenerative diseases is the deposition of α-synuclein (α-syn) fibrils in the Lewy body. The central hydrophobic region of α-synuclein is similar to the α-synuclein peptide (71-82), which is considered to be the cause of protein aggregation. Furthermore, α-synuclein (71-82) forms amyloid fibrillary with similar morphology to α-synuclein, suggesting that this region participates in the fibrillogenic core of the full-length protein.

Category
Functional Peptides
Catalog number
BAT-014849
CAS number
332867-16-0
Molecular Formula
C51H92N14O17
Molecular Weight
1173.36
Synonyms
α-syn (71-82) (human); H-Val-Thr-Gly-Val-Thr-Ala-Val-Ala-Gln-Lys-Thr-Val-OH
Appearance
White Powder
Purity
≥95%
Sequence
VTGVTAVAQKTV
Storage
Store at -20°C
Solubility
Soluble in DMSO, Water
1. Besides fibrillization: putative role of the peptide fragment 71-82 on the structural and assembly behavior of α-synuclein
Laurie Bédard, Thierry Lefèvre, Émilie Morin-Michaud, Michèle Auger Biochemistry. 2014 Oct 21;53(41):6463-72. doi: 10.1021/bi5008707. Epub 2014 Oct 7.
The fibrillization of α-synuclein (α-syn) is involved in Parkinson's disease, a neurodegenerative disorder that affects four million people in the world. The amino acid sequence 71-82 of this protein (VTGVTAVAQKTV) has appeared to be essential for fibril formation. In the present study, we have investigated the secondary structure and thermal stability of the peptide fragment 71-82, α-syn71-82, as a function of concentration and temperature, as well as its interactions with phospholipid model membranes using various spectroscopic techniques. The data show that α-syn71-82 is mainly disordered in solution with the presence of a few β-sheet structure elements. The peptide reversibly forms intermolecular β-sheets with increasing concentration and decreasing temperature, suggesting that it is subjected to a thermodynamic equilibrium between a monomeric and an oligomeric form. This equilibrium seems to be affected by the presence of zwitterionic membranes. Conversely, the influence of the peptide on zwitterionic lipid bilayers is small and concentration-dependent. By contrast, α-syn71-82 is strongly affected by anionic vesicles. The peptide indeed exhibits a dramatic conformational change, reflecting an extensive and irreversible self-aggregation, the majority of the amino acids being involved in a parallel β-sheet conformation. The aggregates appear to be located near the membrane surface but do not perturb significantly the membrane order. Comparing these results with the literature, it appears that α-syn71-82 shares several general properties and structural similarities with its parent protein. These common points suggest that the sequence 71-82 may overall contribute to the behavior and properties of α-syn.
2. Structure of a Parkinson's Disease-Involved α-Synuclein Peptide Is Modulated by Membrane Composition and Physical State
Benjamin Martial, Gabrielle Raîche-Marcoux, Thierry Lefèvre, Pierre Audet, Normand Voyer, Michèle Auger J Phys Chem B. 2020 Apr 30;124(17):3469-3481. doi: 10.1021/acs.jpcb.0c00945. Epub 2020 Apr 20.
α-Synuclein (AS), the protein responsible for Parkinson's disease, contains a 12-residue-long sequence, AS71-82, that is thought to play a crucial role in the α-synuclein aggregation process. Neuronal membranes are direct interacting partners of α-synuclein and play a role in fibrillogenesis by providing a charged catalytic surface, notably from anionic phospholipids. However, details are lacking regarding the impact of membrane composition and the driving forces leading to membrane anchorage and peptide structure conversion. To decipher the interplay of α-synuclein with neuronal membranes, the structure of AS71-82 was investigated in the presence of anionic model membranes. Infrared (IR) spectroscopy and solid-state nuclear magnetic resonance data show that AS71-82 adopts a perfectly in-register parallel β-sheet structure with fibrillar morphology upon interactions with anionic model membranes. IR thermotropism experiments conducted with several membrane compositions revealed that the phospholipids' phase transition induces a rearrangement of the AS71-82 β-sheet structure. In contrast, membranes are not significantly affected by the presence of AS71-82, which advocates for the amyloid fibrils to lie loosely on the membrane surface. The results bring new arguments for the lipid-sensing capabilities of AS71-82 and revealed its protofibrillar structure. The striking similarities between AS71-82 and α-synuclein make it a potential good aggregation inhibitor upon chemical modifications.
3. Synthetic NAC 71-82 Peptides Designed to Produce Fibrils with Different Protofilament Interface Contacts
Thomas Näsström, Tobias Dahlberg, Dmitry Malyshev, Jörgen Ådén, Per Ola Andersson, Magnus Andersson, Björn C G Karlsson Int J Mol Sci. 2021 Aug 28;22(17):9334. doi: 10.3390/ijms22179334.
Alpha-synucleinopathies are featured by fibrillar inclusions in brain cells. Although α-synuclein fibrils display structural diversity, the origin of this diversity is not fully understood. We used molecular dynamics simulations to design synthetic peptides, based on the NAC 71-82 amino acid fragment of α-synuclein, that govern protofilament contacts and generation of twisted fibrillar polymorphs. Four peptides with structures based on either single or double fragments and capped or non-capped ends were selected for further analysis. We determined the fibrillar yield and the structures from these peptides found in the solution after fibrillisation using protein concentration determination assay and circular dichroism spectroscopy. In addition, we characterised secondary structures formed by individual fibrillar complexes using laser-tweezers Raman spectroscopy. Results suggest less mature fibrils, based on the lower relative β-sheet content for double- than single-fragment peptide fibrils. We confirmed this structural difference by TEM analysis which revealed, in addition to short protofibrils, more elongated, twisted and rod-like fibril structures in non-capped and capped double-fragment peptide systems, respectively. Finally, time-correlated single-photon counting demonstrated a difference in the Thioflavin T fluorescence lifetime profiles upon fibril binding. It could be proposed that this difference originated from morphological differences in the fibril samples. Altogether, these results highlight the potential of using peptide models for the generation of fibrils that share morphological features relevant for disease, e.g., twisted and rod-like polymorphs.
Online Inquiry
Verification code
Inquiry Basket